Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States by Albert Y. Liu, Holly Gundacker, Barbra Richardson, Beatrice A. Chen, Craig Hoesley, Ariane van derStraten, Amanda Brown, May Beamer, Jennifer Robinson, Cindy E. Jacobson, Rachel Scheckter, Katherine Bunge, Jill Schwartz, Andrea Thurman, Jeanna M. Piper, Mark A. Marzinke, the MTN‐038 Protocol Team for the Microbicide Trials Network

Get full text